You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: June 21, 2024

Litigation Details for AbbVie Inc. v. Alvotech hf. (N.D. Ill. 2021)


✉ Email this page to a colleague

« Back to Dashboard


Details for AbbVie Inc. v. Alvotech hf. (N.D. Ill. 2021)

Date Filed Document No. Description Snippet Link To Document
2021-12-21 130 amended complaint U.S. Patent No. 8,231,876 72. U.S. Patent No. 8,231,876 (the “’876 patent”), titled …will constitute infringement of U.S. Patent Nos. 6,805,686, 8,231,876, 8,420,081, 8,663,945, 8,708,968, … INFRINGEMENT OF U.S. PATENT NO. 8,231,876 224. AbbVie incorporates by …DECLARATORY JUDGMENT OF INFRINGEMENT OF U.S. PATENT NO. 8,231,876 237. AbbVie incorporates by … Protector Shroud 2. 8,231,876 Wan Purified Antibody External link to document
2022-02-21 247 status report deadlines for the Ten Patents are as follows: 1 U.S. Patent Nos. 6,805,686, 8,926,975, 8,961,973, 8,999,337…with respect to ten patents that will be subject to a first trial1 (“Ten Patents”). Dkt. 63 (2258); Dkt…the ’559 and ’216 patents based on the allegations previously pled for the ’973 patent. [AbbVie…Defenses of Inequitable Conduct, Unclean Hands, and Patent Misuse in 2258 (Dkt. 69 (2258)). On January…Defenses of Inequitable Conduct, Unclean Hands, and Patent Misuse in 2899 (Dkt. 214 (2899)). The Court has External link to document
2021-11-15 79 stipulation Requests for Production related to U.S. Patent Nos. 6,805,686; 8,999,337; 9,067,992; 9,187,559; 9,512,216;…9,512,216; 11,083,792; and 11,167,030 (the patent issuing from U.S. Patent Application No. 17/137,201) (collectively…collectively, the “Remaining Patents”) by treating the term “Patents- in-Suit” as used in those Requests…served on August 25, 2021, to reflect all ten patents that will be tried in the August 2022 trial; and…Requests as including the Remaining Patents. AbbVie shall substantially complete this production on or before External link to document
2021-11-19 80 other proceeding involving the ’619 patent’s parent, U.S. Patent No. 8,420,081, lends further support to “water…indefinite, with terms in the ’792 patent being the most egregious. That patent, which AbbVie asserts covers…’s so-called “bufferless” patents, one of which, in violation of the Patent Dance confidentiality provisions… ARGUMENT The ’792 Patent The ’792 patent relates to methods for purifying … The ’619 and ’030 Patents The ’619 and ’030 patents share a common specification2 External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.